메뉴 건너뛰기




Volumn 23, Issue 8, 2013, Pages 2281-2287

HCV versus HIV drug discovery: Déjà vu all over again?

Author keywords

Antivirals; CCR5; Clinical development; Combination therapy; HCV; HIV; Integrase; NNI; Non nucleoside; NS3; NS5A; Nucleoside; Polymerase; Protease; Single tablet regimen

Indexed keywords

ABACAVIR; ABT 333; ASUNAPREVIR; ATAZANAVIR PLUS RITONAVIR; BOCEPREVIR; COBICISTAT; DACLATASVIR; DELAVIRDINE; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ELVITEGRAVIR; EMTRICITABINE; GENOMIC DNA; GENOMIC RNA; LOMIBUVIR; MARAVIROC; NEVIRAPINE; RILPIVIRINE; SETROBUVIR; SOFOSBUVIR; TELAPREVIR; TENOFOVIR DISOPROXIL; VALOPICITABINE; ZIDOVUDINE;

EID: 84875462326     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2013.02.070     Document Type: Review
Times cited : (7)

References (59)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.